The U.S. hasn’t done enough to counter the use of technology transfers and supply chain infiltration from countries like China, according to two U.S. senators.

China’s plan to drive down generic drug prices through a centralized bulk procurement program is set to redraw the industry.

For the first time in almost two decades, Apple has lowered its revenue outlook — citing weakness in China’s economy and supply constraints.

Ensuring ethical practices through all of the tiers of a global supply chain is a never-ending challenge. How do we get it right?

For a biopharmaceutical company as large as Pfizer, achieving truly comprehensive supply chain visibility is a mammoth undertaking.